Telpha-Trio

Composition: Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg

Telpha Trio is a powerful triple-drug combination used for the treatment of severe and resistant hypertension. This formulation combines the vascular protection of Telmisartan, smooth BP reduction of Cilnidipine, and the fluid-reducing action of Chlorthalidone. It is highly effective in patients requiring aggressive BP control.

Uses:

• Severe and resistant hypertension
• Patients not controlled with dual therapy
• Reduces heart attack and stroke risk
• Manages fluid retention with strong BP control

Side Effects:

• Dizziness
• Frequent urination
• Low potassium
• Fatigue
• Mild ankle swelling

Other Details:

• Once-daily dosing
• Electrolyte and kidney monitoring required
• Best suited for high-risk hypertensive patients
• Avoid dehydration